Douglas Patrick Atkinson
Known title: Head of Global SalesCIK: 0002074105
Associated companies
Transaction History
| CV | ▲ Buy | Option Exercise | 34,786 | $20K | 5/5/2026 | View on chart |
| CV | ▲ Buy | Option Exercise | 36,036 | $10K | 5/4/2026 | View on chart |
| CV | ▲ Buy | Option Exercise | 30,030 | $11K | 5/4/2026 | View on chart |
| CV | ▲ Buy | Option Exercise | 6,505 | $4K | 5/4/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
CapsoVision Receives FDA Clearance for AI Highlights Tool
CapsoVision has secured FDA clearance for its AI Highlights reading tool on the CapsoCam Plus system. The approval allows the company to market the feature as a medical device, potentially expanding its use in clinical settings. The clearance may enhance the product’s value proposition and support future growth.
CapsoVision Receives FDA Clearance for AI Highlights Tool. CapsoVision has secured FDA clearance for its AI Highlights reading tool on the CapsoCam Plus system. The approval allows the company to market the feature as a medical device, potentially expanding its use in clinical settings. The clearance may enhance the product’s value proposition and support future growth.